Parallel Advisors’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5
| Closed | – | – | 3727 |
|
|
2025
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 3718 |
|
|
2024
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 3646 |
|
|
2024
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 3517 |
|
|
2024
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 3467 |
|
|
2024
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 3458 |
|
|
2023
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 3535 |
|
|
2023
Q3 | $0 | Sell |
5
-21
| -81% | – | ﹤0.01% | 3515 |
|
|
2023
Q2 | $807 | Sell |
26
-31
| -54% | -$962 | ﹤0.01% | 2984 |
|
|
2023
Q1 | $1.2K | Buy |
57
+17
| +43% | +$359 | ﹤0.01% | 2915 |
|
|
2022
Q4 | $917 | Hold |
40
| – | – | ﹤0.01% | 2919 |
|
|
2022
Q3 | $1K | Buy |
40
+14
| +54% | +$350 | ﹤0.01% | 3059 |
|
|
2022
Q2 | $0 | Buy |
26
+21
| +420% | – | ﹤0.01% | 3469 |
|
|
2022
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 3385 |
|
|
2021
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 3391 |
|
|
2021
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 3301 |
|
|
2021
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 3092 |
|
|
2021
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 2929 |
|
|
2020
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 2758 |
|
|
2020
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 2704 |
|
|
2020
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 2787 |
|
|
2020
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 2732 |
|
|
2019
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 2532 |
|
|
2019
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 2534 |
|
|
2019
Q2 | $0 | Buy |
+5
| New | – | ﹤0.01% | 2467 |
|